Ovarian cancer diagnosis and treatment
Ovarian cancer diagnosis and treatment is a research topic within Reproductive Medicine. Science Explorer counts 52k research works in it since 1950. 15.7% of them reached the world's top 10% most cited for their field and year.
This cluster of papers encompasses an extensive exploration of ovarian cancer, including genomic analyses, treatment strategies such as chemotherapy and cytoreductive surgery, identification of biomarkers, investigation of tumor models, mutation analysis, the role of fallopian tube origin in cancer development, metastasis patterns, and insights from clinical trials.
- Ovarian Cancer
- Genomic Analysis
- Chemotherapy
- Cytoreductive Surgery
- Biomarkers
- Tumor Models
- Mutation Analysis
- Fallopian Tube Origin
- Metastasis
- Clinical Trials
- Research works
- 52k fractional, since 1950
- In the world top 10%
- 8.3k per year above
- Top-10% rate
- 15.7% share of its works in the world top 10%
- Growth, 2013–17 → 2018–22
- +28% the tick is no change
This ranks research output and citation impact. It says nothing about the quality of diagnosis, treatment or care.
Which countries lead Ovarian cancer diagnosis and treatment research?
By volume, the United States and China publish the most (2k and 1.4k works in 2022–2025).
By volume, 2022–2025
- 1 United States 2k works
- 2 China 1.4k works
- 3 India 802 works
- 4 Italy 507 works
- 5 Japan 413 works
- 6 United Kingdom 397 works
- 7 Germany 295 works
- 8 South Korea 276 works
- 9 Türkiye 271 works
- 10 France 258 works
How concentrated that is
The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.
Shares of the rows listed above, not of the whole node.
Which institutions lead Ovarian cancer diagnosis and treatment research?
By volume in 2022–2025, The University of Texas MD Anderson Cancer Center publishes the most Ovarian cancer diagnosis and treatment research, followed by Agostino Gemelli University Polyclinic and Memorial Sloan Kettering Cancer Center.
By volume, 2022–2025
- 1 The University of Texas MD Anderson Cancer CenterUnited States 74 works
- 2 Agostino Gemelli University PolyclinicItaly 61 works
- 3 Memorial Sloan Kettering Cancer CenterUnited States 57 works
- 4 All India Institute of Medical SciencesIndia 47 works
- 5 Istituti di Ricovero e Cura a Carattere ScientificoItaly 42 works
- 6 Chinese Academy of Medical Sciences & Peking Union Medical CollegeChina 40 works
- 7 Obstetrics and Gynecology Hospital of Fudan UniversityChina 37 works
- 8 Università Cattolica del Sacro CuoreItaly 32 works
- 9 Sichuan UniversityChina 31 works
- 10 China Medical UniversityChina 27 works
Who are the leading researchers in Ovarian cancer diagnosis and treatment?
The most-cited researchers publishing on Ovarian cancer diagnosis and treatment include Kenneth J. Livak, Elisabete Weiderpass and Gordon B. Mills.
- 1 Kenneth J. Livak United States 20k citations
- 2 Elisabete Weiderpass France 6k citations
- 3 Gordon B. Mills United States 3.7k citations
Ranked by citations received across their whole record, among researchers with at least three works on this topic.
Where is Ovarian cancer diagnosis and treatment research done?
The largest centres of Ovarian cancer diagnosis and treatment research in 2022–2025 are Beijing (China), Seoul (South Korea), London (United Kingdom) and Rome (Italy).
Largest cities, 2022–2025
Where is the best place to study Ovarian cancer diagnosis and treatment?
Among universities, judged by research, China Medical University, Università Cattolica del Sacro Cuore and Carol Davila University of Medicine and Pharmacy score highest, combining excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.
One dot per university in the table below. The upper left is the interesting corner: small places doing unusually strong work.
| # | University | Score | Top 10% | Specialisation | Works | Growth |
|---|---|---|---|---|---|---|
| 1 | China Medical UniversityChina | 66.8 | 31.5% | 9.3× | 27 | -17.3% |
| 2 | Università Cattolica del Sacro CuoreItaly | 62.1 | 19.6% | 12.5× | 32 | +6.5% |
| 3 | Carol Davila University of Medicine and PharmacyRomania | 55.4 | 19.6% | 7.2× | 10 | +1368.0% |
| 4 | Cornell UniversityUnited States | 53.7 | 28.4% | 2.8× | 26 | +79.6% |
| 5 | Medical University of LublinPoland | 50.7 | 9.5% | 9.7× | 14 | +134.1% |
| 6 | Poznan University of Medical SciencesPoland | 50.5 | 21.6% | 7.2× | 11 | +82.6% |
| 7 | Chinese Academy of Medical Sciences & Peking Union Medical CollegeChina | 49.1 | 14.1% | 4.5× | 40 | +109.1% |
| 8 | National and Kapodistrian University of AthensGreece | 47.3 | 19.1% | 4.8× | 22 | +51.1% |
| 9 | Jawaharlal Nehru Medical CollegeIndia | 47.3 | 12.4% | 11.8× | 13 | — |
| 10 | All India Institute of Medical SciencesIndia | 46.2 | 1.7% | 8.4× | 47 | +70.6% |
Universities only. Score blends excellence (30%), specialisation (25%), size (20%), growth (15%) and international reach (10%), 2015–2022; growth compares 2010–14 with 2015–19.
Is Ovarian cancer diagnosis and treatment research growing?
Output in 2018–2022 was 28% higher than in 2013–2017, peaking in 2025. The fastest-growing topics are Ovarian cancer diagnosis and treatment.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Which topics inside it are moving
Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.